Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
The latest update is out from Kanabo Group ( (GB:KNB) ).
Kanabo Group plc announced that Mr. David Tsur will step down from the Board of Directors effective January 30, 2025, after serving as a member since 2021 and holding the position of Chairman for over two years. The company plans to appoint a new UK-based director and will announce this separately. Mr. Tsur has been praised for his significant contributions and mentorship within the company. This leadership transition comes as Kanabo continues to position itself as a leading digital health provider, leveraging its telehealth services and specialized cannabis-based treatments to enhance patient care.
More about Kanabo Group
Kanabo Group plc is a digital health company that focuses on transforming patient care through innovative technology platforms and specialized treatment offerings. Since its inception in 2017, the company has dedicated itself to researching, developing, and commercializing regulated medicinal cannabis-derived formulations and therapeutic inhalation devices. Kanabo also provides telehealth services through its NHS-approved platform and has expanded its chronic pain management clinic, Treat-It, into multiple locations.
YTD Price Performance: 5.88%
Average Trading Volume: 317,734
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £5.69M
See more data about KNB stock on TipRanks’ Stock Analysis page.
